Stryker Corporation provided earnings guidance for the year 2022. Considering third quarter results, the strong order book for capital equipment and the sales momentum in implant and capital businesses, the company now expects full year 2022 organic net sales growth to be in the range of 8.5% to 9.0%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
335.5 USD | +1.64% | +0.26% | +12.05% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.05% | 128B | |
-9.24% | 10.88B | |
+0.29% | 8.76B | |
+36.99% | 5.48B | |
-21.98% | 4.72B | |
+8.02% | 3.43B | |
-10.32% | 2.76B | |
-12.33% | 2.06B | |
-13.53% | 1.92B | |
-28.80% | 1.65B |
- Stock Market
- Equities
- SYK Stock
- News Stryker Corporation
- Stryker Corporation Provides Earnings Guidance for the Year 2022